News

Merck beats Q1 2025 estimates despite Gardasil sales drop, driven by Vaxneuvance, Winrevair & Welireg. Click here to find out ...
Taking a statin medication is an effective, safe, and low-cost way to lower cholesterol and reduce risk of cardiovascular events. Despite clinicians recommending that many patients with diabetes take ...
Dr. Bika holds a Ph.D. in Materials Science and Engineering from the University of Pennsylvania, a Master of Science in ...
This downturn can be attributed to several factors: a lowered guidance for 2025 and growing concerns about the long-term ...
Gilead Sciences, Inc. GILD announced positive top-line results from yet another late-stage study on breast cancer drug, ...
Last month, an average of about 350 people died each week from COVID, according to data from the CDC. With available vaccines ...
This browser is no longer supported at MarketWatch. For the best MarketWatch.com experience, please update to a modern browser.
A Bay Area biotech company that laid off dozens of people this week has blamed the job cuts on policies of the Trump ...
The State of Kansas announced an $895 million capital expansion project at the Merck Animal Health manufacturing facility in ...
Merck & Co. is undervalued with strong oncology growth, key R&D investments, and shareholder returns. Click here to read an ...
ZoomRx polled 50 experienced oncologists and hemato-oncologists about 20 cancer drugmakers, asking the doctors to rank the ...